chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Musculoskeletal stiffness, Neck pain, Pain in extremity
Clinical narrative: sore arm; pounding headache/throbbing headache/woke up with a horrible headache/ it was extremely painful; hand was shaking so badly, it was like I had Parkinson; it was trembling so bad; stiff neck and shoulder muscle/shoulder and neck was still very stiff and sore; my shoulder and neck was still very stiff and sore; my shoulder and neck was still very stiff and sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administration date 08Mar2021 (Lot number: EN6199) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Patient on very low dose blood pressure pill; "brain aneurysm" (unspecified if ongoing); "Parkinson's" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; HEADACHE (non-serious), outcome "not recovered", described as "pounding headache/throbbing headache/woke up with a horrible headache/ it was extremely painful"; TREMOR (non-serious), outcome "unknown", described as "hand was shaking so badly, it was like I had Parkinson; it was trembling so bad"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "not recovered", described as "stiff neck and shoulder muscle/shoulder and neck was still very stiff and sore"; NECK PAIN (non-serious), ARTHRALGIA (non-serious), outcome "not recovered" and all described as "my shoulder and neck was still very stiff and sore". Therapeutic measures were taken as a result of pain in extremity, headache, musculoskeletal stiffness, neck pain, arthralgia. Additional information: Consumer stated that, she had a sore arm and a stiff neck and shoulder muscle but the worst thing she had was at 03:00 in the morning, she woke up with a horrible headache, throbbing headache and exactly it was as bad as when she had a ruptured brain aneurysm, it was extremely painful. So, she got up to take a Tylenol and was trying to pour a Tylenol into her hand, her hand was shaking so badly that was holding a bottle, it was like she had Parkinson and the pill end up going all over the floor because it was shaking, trembling so bad. Caller was worried about receiving the second dose due to her reaction to the first dose. Caller was thinking of taking Johnson and Johnson as her second shot instead of the Pfizer. Caller stated that, she took Tylenol and then in the morning when she got up, her shoulder and neck was still very stiff and sore, so she took some Ibuprofen in the morning.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: sore arm; pounding headache/throbbing headache/woke up with a horrible headache/ it was extremely painful; hand was shaking so badly, it was like I had Parkinson; it was trembling so bad; stiff neck and shoulder muscle/shoulder and neck was still very stiff and sore; my shoulder and neck was still very stiff and sore; my shoulder and neck was still very stiff and sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administration date 08Mar2021 (Lot number: EN6199) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Patient on very low dose blood pressure pill; "brain aneurysm" (unspecified if ongoing); "Parkinson's" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; HEADACHE (non-serious), outcome "not recovered", described as "pounding headache/throbbing headache/woke up with a horrible headache/ it was extremely painful"; TREMOR (non-serious), outcome "unknown", described as "hand was shaking so badly, it was like I had Parkinson; it was trembling so bad"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "not recovered", described as "stiff neck and shoulder muscle/shoulder and neck was still very stiff and sore"; NECK PAIN (non-serious), ARTHRALGIA (non-serious), outcome "not recovered" and all described as "my shoulder and neck was still very stiff and sore". Therapeutic measures were taken as a result of pain in extremity, headache, musculoskeletal stiffness, neck pain, arthralgia. Additional information: Consumer stated that, she had a sore arm and a stiff neck and shoulder muscle but the worst thing she had was at 03:00 in the morning, she woke up with a horrible headache, throbbing headache and exactly it was as bad as when she had a ruptured brain aneurysm, it was extremely painful. So, she got up to take a Tylenol and was trying to pour a Tylenol into her hand, her hand was shaking so badly that was holding a bottle, it was like she had Parkinson and the pill end up going all over the floor because it was shaking, trembling so bad. Caller was worried about receiving the second dose due to her reaction to the first dose. Caller was thinking of taking Johnson and Johnson as her second shot instead of the Pfizer. Caller stated that, she took Tylenol and then in the morning when she got up, her shoulder and neck was still very stiff and sore, so she took some Ibuprofen in the morning.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: UNK
Symptoms: Potentiating drug interaction, SARS-CoV-2 test
Clinical narrative: Patient reports that about 2 weeks ago he received antibody therapy for Sars-CoV-2; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: POTENTIATING DRUG INTERACTION (non-serious) with onset 2021, outcome "unknown", described as "Patient reports that about 2 weeks ago he received antibody therapy for Sars-CoV-2". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information included: Patient had 1st dose of Covid vaccine 3 weeks ago and was due for 2nd dose on the date of reporting. It was reported that second dose of Pfizer-Biontech Covid19 vaccine might delay due to antibody therapy. Patient did not confirm whether he had an active infection.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Off label use, Pain, Product use issue
Clinical narrative: I did receive my shingles vaccine in between my first and second dose of the covid vaccine on 19Feb2021; I did receive my shingles vaccine in between my first and second dose of the covid vaccine on 19Feb2021; Yesterday I started aching all the way to my bones; chills; felt a little puny last week; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 85 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Feb2021 (Lot number: EN6198) at the age of 85 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid" (unspecified if ongoing); "blood pressure" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: DIOVAN taken for blood pressure measurement; COREG CR taken for blood pressure measurement; OMEPRAZOLE; EZETIMIBE taken for blood cholesterol; TYLENOL. Vaccination history included: Bnt162b2 (1st dose, Lot number: EL8982, Anatomical Location: left arm), administration date: 24Jan2021, when the patient was 85 years old, for Covid-19 immunisation; Shingrix (She got her shingles vaccine on the 19Feb2021, Prior Vaccinations (within 4 weeks)), administration date: 19Feb2021, when the patient was 85 years old. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious), outcome "unknown" and all described as "I did receive my shingles vaccine in between my first and second dose of the covid vaccine on 19Feb2021"; PAIN (non-serious) with onset 09Mar2021, outcome "unknown", described as "Yesterday I started aching all the way to my bones"; CHILLS (non-serious) with onset 09Mar2021, outcome "unknown", described as "chills"; MALAISE (non-serious) with onset Mar2021, outcome "recovering", described as "felt a little puny last week". Therapeutic measures were taken as a result of pain, chills. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: felt a little sore in his arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "felt a little sore in his arm".  Additional information: The patient only felt a little sore in his arm. He did not see where the needle came from when he received his vaccine and would like to know how it was supposed to be stored and how were they storing it at the location he received my vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Sleep disorder, Vomiting
Clinical narrative: he could not sleep all night; has a deep pain where the sciatic nerve begins, in the lower back towards the belly, he can't sit, he has been standing for hours, walking, if he sits or lies down, the pain worsens; has a deep pain where the sciatic nerve begins, in the lower back towards the belly, he can't sit, he has been standing for hours, walking, if he sits or lies down, the pain worsens; vomited; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 67 year-old male patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SLEEP DISORDER (non-serious) with onset 2021, outcome "unknown", described as "he could not sleep all night"; PAIN (non-serious), PAIN (non-serious) all with onset 2021, outcome "unknown" and all described as "has a deep pain where the sciatic nerve begins, in the lower back towards the belly, he can't sit, he has been standing for hours, walking, if he sits or lies down, the pain worsens"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "vomited".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine
Clinical narrative: headache; migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), administration date: 05Feb2021, for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; MIGRAINE (non-serious), outcome "unknown", described as "migraine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Diarrhoea, Nausea, Vomiting
Clinical narrative: I am considering not getting the second shot; diarrhea; vomiting; Nausea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Mar2021 12:30 (Lot number: EN6202) at the age of 79 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "large prostate" (unspecified if ongoing), notes: Diagnosed years ago, he had a part of his prostate shaved off surgically years ago and he has been put on medicine and is following with the urologist.; "slight high blood pressure" (unspecified if ongoing), notes: Diagnosed a long time ago, many years ago.; "Surgery" (unspecified if ongoing), notes: he had a major surgery, but no additional details provided. The patient took concomitant medications. The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "I am considering not getting the second shot"; NAUSEA (non-serious) with onset 10Mar2021 22:00, outcome "recovered" (Mar2021), described as "Nausea"; DIARRHOEA (non-serious) with onset 11Mar2021, outcome "recovered" (Mar2021), described as "diarrhea"; VOMITING (non-serious) with onset 11Mar2021, outcome "recovered" (Mar2021), described as "vomiting".  Additional information: No Prior Vaccinations (within 4 weeks). The patient did not visit to Emergency room or Physician's office. No Family Medical History Relevant to AE. The patient had coffee and toast. The caller is on daily medication and hasn't had this reaction before, so he does not believe they caused this reaction. The caller mentions he takes a low dose blood pressure medication. No additional details provided regarding his other medications. Patient was scheduled for 28 days after Tuesday for his second dose, which he did not think he's going to get, because of the reaction they had.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Musculoskeletal stiffness, Myalgia, Pain
Clinical narrative: arm is very sore; headache; tight/stiff neck; weak; muscle pain; achy all over; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm is very sore"; HEADACHE (non-serious), outcome "unknown", described as "headache"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "tight/stiff neck"; ASTHENIA (non-serious), outcome "unknown", described as "weak"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain"; PAIN (non-serious), outcome "unknown", described as "achy all over".  Additional information: Patient is taking ibuprofen periodically for the pain. She was asking if she can take Tylenol or ibuprofen. She spoke to a pharmacist regarding this concern but she was advised not to take the pain reliever before and after taking the vaccine shot because it will lessen the effectiveness of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is very sore; headache; tight/stiff neck; weak; muscle pain; achy all over; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm is very sore"; HEADACHE (non-serious), outcome "unknown", described as "headache"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "tight/stiff neck"; ASTHENIA (non-serious), outcome "unknown", described as "weak"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain"; PAIN (non-serious), outcome "unknown", described as "achy all over".  Additional information: Patient is taking ibuprofen periodically for the pain. She was asking if she can take Tylenol or ibuprofen. She spoke to a pharmacist regarding this concern but she was advised not to take the pain reliever before and after taking the vaccine shot because it will lessen the effectiveness of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Vision blurred
Clinical narrative: right eye was totally blurry and couldn't see out of it; really bad headache on the right side of her head by her right eye; Nausea; lightheadedness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Mar2021 10:20 (Lot number: EN6204, Expiration Date: Jun2021) at the age of 37 years as dose 1, single dose for covid-19 immunisation. Relevant medical history included: "Migraine" (ongoing), notes: Started when she was around 13 or 14 years old. There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 10Mar2021, outcome "not recovered", described as "really bad headache on the right side of her head by her right eye"; VISION BLURRED (non-serious) with onset 11Mar2021, outcome "recovered" (11Mar2021), described as "right eye was totally blurry and couldn't see out of it"; NAUSEA (non-serious) with onset 09Mar2021, outcome "recovering", described as "Nausea"; DIZZINESS (non-serious) with onset 09Mar2021, outcome "recovered" (10Mar2021), described as "lightheadedness". Therapeutic measures were taken as a result of headache.  additional information: Caller states that she has been alternating taking Ibuprofen and Tylenol. She clarifies that it helps a bit but then comes back and she still has a headache. Ibuprofen: Lot: OAE3317 A, Tylenol: Lot: PMA102  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: muscle aches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot unknown=False,, dose number=1), for COVID-19 immunisation. The following information was reported: MYALGIA (non-serious) with onset 09Mar2021, outcome "recovering", described as "muscle aches". It was unknown if therapeutic measures were taken as a result of myalgia. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal
Clinical narrative: it hit her like boom and she needed to pass out; feeling exhausted; Extremely Tired/feels so tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2021 09:06 (Lot number: EN6207, Expiration Date: 31Jul2021) at the age of 59 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Verbatim: High Blood Pressure" (ongoing), notes: Verbatim: High Blood Pressure; Diagnosed 4 years ago. Concomitant medication(s) included: LOVASTATIN taken for hypertension (ongoing). The following information was reported: FATIGUE (non-serious) with onset 11Mar2021 11:30, outcome "recovering", described as "Extremely Tired/feels so tired"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "it hit her like boom and she needed to pass out"; FATIGUE (non-serious), outcome "unknown", described as "feeling exhausted".  Additional information: Caller stated by saying her son and her, then shouted something to her son in the distance and stated there were bears up here and he didn't take the bear spray, tells him don't go for a hike and stay put, she did not want him in the woods by himself, stated his dad usually goes with him but was yapping on the phone like usual. Her son had his shot today too. At his injection site, he felt numbness and the site became swollen and enlarged to the size of the palm of your hand. He complained about it on the one-hour way home. She thought, does she need to take him to a doctor? The swelling went down but now he was tired. She went to bed at midnight, but she was ok on 5.5 hours of sleep She could say hers was from the vaccine because it hit her like boom, and she needed to pass out. Vaccination Facility Type was Drive Thru. No additional vaccines administered on same date of the Pfizer suspect. Adverse event did not require a visit to Emergency Room/Physician Office. No vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. No Adverse events following prior vaccinations. No relevant family medical history to adverse event. She stated that her mom was 97 and got 2 Moderna with no symptoms, she didn't even know she got it.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nervousness, Tremor
Clinical narrative: really shaky and felt like he might pass out; dizziness/got really dizzy and felt like he was going to pass out; tired; He went home and sat down because he was shaky.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 11:00 (Lot number: EN6200) at the age of 72 years as dose 1 single for covid-19 immunisation. Relevant medical history included: "blood thinner" (unspecified if ongoing); "blood pressure and controlling his pacemaker" (unspecified if ongoing); "potassium runs low" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL taken for hypertension; ELIQUIS taken for anticoagulant therapy; POTASSIUM taken for hypokalaemia. The following information was reported: FATIGUE (non-serious) with onset 05Mar2021, outcome "recovered" (07Mar2021), described as "tired"; TREMOR (non-serious) with onset 06Mar2021, outcome "recovered" (06Mar2021), described as "really shaky and felt like he might pass out"; DIZZINESS (non-serious) with onset 06Mar2021, outcome "recovered" (06Mar2021), described as "dizziness/got really dizzy and felt like he was going to pass out"; NERVOUSNESS (non-serious) with onset Mar2021, outcome "unknown", described as "He went home and sat down because he was shaky."  Additional information: The caller stated he got his first shot on 04Mar2021 and had a side effect on 05Mar2021 of being tired. On 06Mar2021 he was really shaky and felt like he might pass out. On Sunday he was okay. He stated he has a pacemaker and called the cardiologist and they didn't see anything different with the download and his cardiologist said he could get his second dose. The caller wanted to know if dizziness and shakiness was a side effect and if so what concern does he have for the second shot. Duration for really tired was 2 days. Metoprolol XL was given 75mg, twice a day, orally, Eliquis was 5mg, twice a day (morning and night), orally, KCC/ Potassium, 10mg, once a day, orally. Metoprolol XL: Started taking about a year and a half ago. Eliquis: He's been taking for 3 years. KCC/ Potassium: He's been taking for about 10 years.States that whenever he got really dizzy, felt like he was going to pass out. He went home and sat down because he was shaky. Metoprolol XL: Caller mentions he does get hits on his lower chamber of his pacemaker once in a while so it was supposed to help eliminate it. When proving indication for KCC, stated his potassium runs low because of the Eliquis.  Eliquis: Does not see NDC/LOT or EXP. Clarifies it was dispensed in a pharmacy bottle. Stated he needed to grab his reading glasses to read the bottle Dispense date: 20Oct2020 Use by: 20Oct2021. he doesn't think so, he has had a couple of ablations but went to the pacemaker after a couple of ablations.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: She states after her first vaccine dose her arm "was a lot more painful than the 2nd dose and lasted for days/sore arms; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "She states after her first vaccine dose her arm "was a lot more painful than the 2nd dose and lasted for days/sore arms"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  Additional information: The patient stated after receiving her dose on Tuesday, the nurse vaccinated her said, oh it was oozing and wiped it with an alcohol wipe and put a band aid on it. There was liquid 3 inches down my arm. The patient asked her if she was sure got all the medication and she said yes. But the patient was not so sure. The patient wants to know the full efficacy of the vaccine since she got both of the Pfizer Covid-19 Vaccine.  Medical Information (Live Operators Only): Were any unaddressed medical questions referred or forwarded to Medical Information: Yes . No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: mild symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 27Jan2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Tested pos.: 12Jan2021), administration date: 06Jan2021, for Covid-19 immunization, reaction(s): "Tested pos.". The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "mild symptoms".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Lethargy
Clinical narrative: light headedness; chills; drowsiness; fatigue; lethargy; headache; body ache; Muscular pain in arm that received vaccine for 48 hours; Headache after 12 hours; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021273425 (Pfizer).  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Feb2021 02:30 (Lot number: EN6200) as dose 1, single and administered in arm left, administration date 09Mar2021 02:30 (Lot number: EN6200) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Vaccination history included: Bnt162b2 (Dose number: 1, Time: 02:30AM, Anatomical site of injection: Left arm, Batch/Lot number: EN6200), administration date: 16Feb2021, when the patient was 42 years old, for COVID-19 immunization. The following information was reported: MYALGIA (non-serious) with onset 17Feb2021 03:00, outcome "recovered" (2021), described as "Muscular pain in arm that received vaccine for 48 hours"; HEADACHE (non-serious) with onset 17Feb2021 03:00, outcome "recovered" (2021), described as "Headache after 12 hours"; DIZZINESS (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "light headedness"; CHILLS (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "chills"; SOMNOLENCE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "drowsiness"; FATIGUE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "fatigue"; LETHARGY (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "lethargy"; HEADACHE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "headache"; PAIN (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "body ache". Therapeutic measures were not taken as a result of myalgia, headache, dizziness, chills, somnolence, fatigue, lethargy, headache, pain.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Somnolence
Clinical narrative: light headedness; chills; drowsiness; fatigue; lethargy; headache; body ache; Muscular pain in arm that received vaccine for 48 hours; Headache after 12 hours; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021273425 (Pfizer).  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Feb2021 02:30 (Lot number: EN6200) as dose 1, single and administered in arm left, administration date 09Mar2021 02:30 (Lot number: EN6200) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Vaccination history included: Bnt162b2 (Dose number: 1, Time: 02:30AM, Anatomical site of injection: Left arm, Batch/Lot number: EN6200), administration date: 16Feb2021, when the patient was 42 years old, for COVID-19 immunization. The following information was reported: MYALGIA (non-serious) with onset 17Feb2021 03:00, outcome "recovered" (2021), described as "Muscular pain in arm that received vaccine for 48 hours"; HEADACHE (non-serious) with onset 17Feb2021 03:00, outcome "recovered" (2021), described as "Headache after 12 hours"; DIZZINESS (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "light headedness"; CHILLS (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "chills"; SOMNOLENCE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "drowsiness"; FATIGUE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "fatigue"; LETHARGY (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "lethargy"; HEADACHE (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "headache"; PAIN (non-serious) with onset 10Mar2021 09:00, outcome "recovered with sequelae" (2021), described as "body ache". Therapeutic measures were not taken as a result of myalgia, headache, dizziness, chills, somnolence, fatigue, lethargy, headache, pain.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: earache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "headache" (unspecified if ongoing), notes: She previously had a headache that developed into the earache. The patient's concomitant medications were not reported. The following information was reported: EAR PAIN (non-serious) with onset 10Mar2021, outcome "unknown", described as "earache".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Felt unwell; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunisation. The following information was reported: MALAISE (non-serious) with onset 12Mar2021, outcome "recovered" (Mar2021), described as "Felt unwell". Therapeutic measures were not taken as a result of malaise.  Additional information: It was unknown if patient receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient received any other medications within 2 weeks of vaccination was unknown. Prior to vaccination, it was unknown if patient diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient been tested for COVID-19. Known allergies was unknown and Other medical history was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 11Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Ibuprofen, notes: He normally takes aspirin every day and took Ibuprofen the day before his vaccine and asked if this will effect the efficacy. The following information was reported: HEADACHE (non-serious) with onset 11Mar2021, outcome "unknown", described as "headache". Therapeutic measures were taken as a result of headache.  Additional information: The patient had received his first vaccine dose, the patient takes aspirin everyday and took ibuprofen the day before his vaccine and asked if ibuprofen effects the efficacy. The patient took aspirin for a headache 8 hours after vaccine dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Oral pruritus
Clinical narrative: 20 min after vaccination itching at roof of mouth; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "allergies" (unspecified if ongoing), notes: known allergies: Yes. The patient's concomitant medications were not reported. The following information was reported: ORAL PRURITUS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "20 min after vaccination itching at roof of mouth". It was unknown if therapeutic measures were taken as a result of oral pruritus. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: Swollen ly nodes in left arm; Pain at site of injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 10:15 (Lot number: EL3247) at the age of 50 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: RITALIN. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 12Mar2021 14:00, outcome "recovering", described as "Pain at site of injection"; LYMPHADENOPATHY (non-serious) with onset 13Mar2021 10:00, outcome "recovering", described as "Swollen ly nodes in left arm". Therapeutic measures were not taken as a result of vaccination site pain, lymphadenopathy.  Additional information: The patient received the vaccine on Friday. She became aware of the first AE (pain in injection site) -4 hours after vaccination and of the second AE (swollen lymph nodes) when she woke up the following morning. The patient did not have any other vaccine in four weeks. The patient did not have covid prior vaccination. The patient was not tested for covid post vaccination. The patient did not have any known allergies.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Fatigue, Feeding disorder, Headache
Clinical narrative: Dry heaves; Chills/My teeth just chattered and very tired; My teeth just chattered and very tired; Headache; Wasn't really able to eat anything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administration date 07Mar2021 (Batch/Lot number: unknown) at the age of 81 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Rapid Heart beat" (unspecified if ongoing), notes: Rapid Heart beat; "blood thinner" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; BUMETANIDE; BUFFERIN taken for anticoagulant therapy; SIMVASTATIN. The following information was reported: RETCHING (non-serious) with onset 08Mar2021, outcome "unknown", described as "Dry heaves"; CHILLS (non-serious) with onset 08Mar2021, outcome "unknown", described as "Chills/My teeth just chattered and very tired"; FATIGUE (non-serious) with onset 08Mar2021, outcome "unknown", described as "My teeth just chattered and very tired"; HEADACHE (non-serious) with onset 08Mar2021, outcome "unknown", described as "Headache"; FEEDING DISORDER (non-serious) with onset 08Mar2021, outcome "unknown", described as "Wasn't really able to eat anything". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of retching, chills, fatigue, headache, feeding disorder. Additional information: Consumer stated, she saw her doctor because she thought she was having some side effects from the Covid Pfizer BioNTech (Covid Vaccine). Patient had the shot this was the first one and she had it on Sunday afternoon probably going on 4 PM. Everything was fine, everything was fine all over the night. But the next morning she started having dry heaves and chills. Her teeth just chattered and very tired. She had a friend who took her to see the doctor and she had headache, wasn't really able to eat anything and he looked at the information that she got when she received the shot. Now the second day which was yesterday I felt better but not so much in the morning, but she ate something at noon. The consumer mentioned that events would have been started on 08Mar2021. Consumer stated, she thinks concomitant product was generic form of Claritin Sinus (Not clarified). The patient takes lot of vitamins. When she don't feel good because she couldn't eat. Patient took the heart medicine and all that but not the vitamins so on.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Retching
Clinical narrative: Dry heaves; Chills/My teeth just chattered and very tired; My teeth just chattered and very tired; Headache; Wasn't really able to eat anything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administration date 07Mar2021 (Batch/Lot number: unknown) at the age of 81 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Rapid Heart beat" (unspecified if ongoing), notes: Rapid Heart beat; "blood thinner" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; BUMETANIDE; BUFFERIN taken for anticoagulant therapy; SIMVASTATIN. The following information was reported: RETCHING (non-serious) with onset 08Mar2021, outcome "unknown", described as "Dry heaves"; CHILLS (non-serious) with onset 08Mar2021, outcome "unknown", described as "Chills/My teeth just chattered and very tired"; FATIGUE (non-serious) with onset 08Mar2021, outcome "unknown", described as "My teeth just chattered and very tired"; HEADACHE (non-serious) with onset 08Mar2021, outcome "unknown", described as "Headache"; FEEDING DISORDER (non-serious) with onset 08Mar2021, outcome "unknown", described as "Wasn't really able to eat anything". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of retching, chills, fatigue, headache, feeding disorder. Additional information: Consumer stated, she saw her doctor because she thought she was having some side effects from the Covid Pfizer BioNTech (Covid Vaccine). Patient had the shot this was the first one and she had it on Sunday afternoon probably going on 4 PM. Everything was fine, everything was fine all over the night. But the next morning she started having dry heaves and chills. Her teeth just chattered and very tired. She had a friend who took her to see the doctor and she had headache, wasn't really able to eat anything and he looked at the information that she got when she received the shot. Now the second day which was yesterday I felt better but not so much in the morning, but she ate something at noon. The consumer mentioned that events would have been started on 08Mar2021. Consumer stated, she thinks concomitant product was generic form of Claritin Sinus (Not clarified). The patient takes lot of vitamins. When she don't feel good because she couldn't eat. Patient took the heart medicine and all that but not the vitamins so on.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Heart rate
Clinical narrative: fatigue; no appetite; nauseous; chills; headache; Sore arm; My pulse was over 100 again resting but went back normal by late morning; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient received bnt162b2 (BNT162B2), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), administration date: 16Feb2021, for COVID-19 immunisation, reaction(s): "Slight sore arm", "headache", "total fatigue", "loss of appetite", "pulse went up 139". The following information was reported: FATIGUE (non-serious) with onset 10Mar2021, outcome "unknown", described as "fatigue"; DECREASED APPETITE (non-serious) with onset 10Mar2021, outcome "unknown", described as "no appetite"; NAUSEA (non-serious) with onset 10Mar2021, outcome "unknown", described as "nauseous"; CHILLS (non-serious) with onset 09Mar2021, outcome "not recovered", described as "chills"; PULSE ABNORMAL (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "My pulse was over 100 again resting but went back normal by late morning"; HEADACHE (non-serious) with onset 09Mar2021, outcome "unknown", described as "headache"; PAIN IN EXTREMITY (non-serious) with onset 09Mar2021, outcome "unknown", described as "Sore arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Onset latency for the events fatigue, decreased appetite and nausea was 01 day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.